ATLANTA, Nov. 5, 2024
/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a
leading cardiac and vascular surgery company focused on aortic
disease, today announced that it will participate in two upcoming
investor conferences.
Artivion's management team will present at the
upcoming Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, at the Lotte New York
Palace. The Company's presentation is scheduled to begin at
1:15p.m. ET. A live webcast can be
accessed through Artivion's website, www.artivion.com, on the
Investors page. An archived copy of the webcast will be available
for 90 days on the same website.
Members of the management team will also host one-on-one
meetings at the upcoming Canaccord Genuity MedTech, Diagnostics and
Digital Health & Services Forum on Thursday, November 21, 2024, in New York. Due to the format of this event no
webcast will be available.
About Artivion, Inc.
Headquartered in suburban
Atlanta, Georgia, Artivion, Inc.
is a medical device company focused on developing simple, elegant
solutions that address cardiac and vascular surgeons' most
difficult challenges in treating patients with aortic diseases.
Artivion's four major groups of products include: aortic stent
grafts, surgical sealants, On-X mechanical heart valves, and
implantable cardiac and vascular human tissues. Artivion markets
and sells products in more than 100 countries worldwide. For
additional information about Artivion, visit our website,
www.artivion.com.
|
Contacts:
|
|
|
Artivion
|
Gilmartin Group
LLC
|
|
Lance A.
Berry
|
Brian Johnston / Laine
Morgan
|
|
Executive Vice
President &
|
Phone:
332-895-3222
|
|
Chief Financial
Officer
|
investors@artivion.com
|
|
Phone:
770-419-3355
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302296852.html
SOURCE Artivion, Inc.
